StayCurrentMD · Error Traps and Culture of Safety in Pediatric Surgical Oncology
Follow
Video·Published Sep 2019Older

Error Traps and Culture of Safety in Pediatric Surgical Oncology

With Dr. Pablo Daval
Try
Intelligent Search· scoped to neuroblastoma · not medical adviceSearch the whole library →
Only a few other public items share this expert — go deeper there →
What the experts said13 expert statements
The three most frequent extracranial solid tumors in pediatric surgical oncology are neuroblastoma, hepatoblastoma, and Wilms tumor.
EpidemiologicalPablo Daval
For neuroblastoma, hepatoblastoma, and Wilms tumor, the surgeon should know when to perform upfront resection versus delaying until neoadjuvant chemotherapy has reduced tumor size and risks.
ClinicalPablo Daval
Avoiding vascular lesions is key in all three tumor types (neuroblastoma, hepatoblastoma, and Wilms tumor).
ClinicalPablo Daval
Implementation of IRDFs (image-defined risk factors) in neuroblastoma can help achieve better resection.
ClinicalPablo Daval
Exposure should be adequate and dissection thorough in pediatric solid tumor surgery.
ClinicalPablo Daval
Some pediatric solid tumor cases can be done with minimally invasive surgery, while others require complex approaches.
ClinicalPablo Daval
The PRETEXT staging system in hepatoblastoma has proven to have prognostic implications.
ClinicalPablo Daval
The PRETEXT staging system can guide hepatoblastoma surgery while maintaining goals of complete resection without postoperative liver failure.
ClinicalPablo Daval
In Wilms tumor surgery, the surgeon should avoid intraoperative rupture and vascular lesions.
ClinicalPablo Daval
Lymph nodes should always be obtained during Wilms tumor surgery.
ClinicalPablo Daval
In bilateral Wilms tumors, preservation of as much renal parenchyma as possible is the aim.
ClinicalPablo Daval
Surgical planning for pediatric solid tumors relies on imaging studies.
ClinicalPablo Daval
The use of 3D printed models, if available, can add to surgical planning for pediatric solid tumors.
ClinicalPablo Daval